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CLINICAL OBSERVATIONS ON TERRAMYCIN*t
FRANCIS G. BLAKE, GEORGE J. FRIOU, AND ROBERT R. WAGNER
In a recent report, Finlay, Hobby, and their collaborators1 have described
a new crystalline antibiotic, terramycin, isolated from broth cultures of a
new actinomycete, Streptomnyces rimosus. In vitro studies8 of terramycin
and its salts have shown that this antibiotic in low concentrations is a
highly effective bacteriostatic agent against a wide variety of gram-positive
and gram-negative bacteria. In vivo observations8 have also shown that it
is a highly effective therapeutic agent against experimental animal infec-
tions with terramycin-sensitive organisms. It possesses low toxicity.1'8
Studies' on absorption and excretion in dogs and rabbits have shown that
terramycin salts are absorbed readily following either oral or parenteral
administration, the most satisfactory results having been obtained on oral
administration of the hydrochloride. It would appear from the foregoing
experimental data that terramycin should be an effective antibiotic agent
for the treatment of a variety of infections in man.3" A therapeutic evalua-
tion has, therefore, been undertaken,8 in which we have had the opportunity
to participate.
The present report records our clinical experience to date with the use
of terramycin in fifteen patients with various infections.
Methods
Selection of patients. The patients selected for treatment were arbitrarily
chosen to represent a considerable variety of infections, in some of whom
other chemotherapeutic agents had been ineffective.
Dosage. Terramycin hydrochloride administered orally was used in all
cases. An initial or loading dose of 1.0 gm. q.h. for three doses was given
in 10 patients, of 1.0 gm. in 5 patients. Subsequent treatment varied from
3.0 to 6.0 gm. per day given in 0.5 gm. or 0.75 gm. doses q.3 h. or q.4 h.
depending on the nature of the illness and response to treatment. In seven
instances the dosage was reduced to 0.25 gm. q.4 h. toward the end of
* From the Department of Internal Medicine, Yale University School of Medicine
and the Medical Service of the Grace-New Haven Community Hospital, University
Service.
t The terramycin used was supplied by Chas. Pfizer & Co., Inc., Brooklyn, New
York, through the courtesy of Dr. Gladys L. Hobby.
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treatment. In one patient (Case E.S.) the initial dose of 4.0 gm. was
followed by 0.5 gm. q.2 h. for 12 doses.
Sensitivity. The sensitivity of the infecting microorganisms to terramycin
hydrochloride was determined in 13 cases by the method described by
Hobby et al.,8 the dilutions used providing end points of 0.25, 0.5, 1.0, 2.0,
4.0, 8.0, and 50.0 micrograms (pg.) per cc. Since it is obvious that these
end points are fairly widely spaced, the sensitivity may have been somewhat
greater than that recorded. The results are recorded in the case reports.
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CHART. 1. Case J.S. Staphylococcus aureus septicemia and mitral endocarditis.
Case reports
The patients selected for treatment with terramycin were 1 case of
acute staphylococcal endocarditis, 2 of subacute streptococcal endocarditis,
4 of pneumococcal lobar pneumonia, 4 urinary tract infections, and a
miscellaneous group of 1 case each of staphylococcal pyoderma, buccal
and penile fusospirochetosis, influenza, and cholangeitis lenta. Pertinent
data concerning them are presented below and summarized in Table 1.
Selected cases are further illustrated in Charts 1-6.
Case J.S., age 19, female. Chart 1. Staphylococcus aureus septicemia with acute
mitral endocarditis and embolic left-sided hemiplegia. This patient, the growth of
whose Staphylococcus aureus was inhibited by 2.0 fig./cc. of terramycin, by 4 un./cc.
Of penicillin, but not by 5.0 Mg./cc. of chioromycetin, was admitted on February 8,
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1950, severely ill and semicomatose, on the ninth day of disease, after having failed to
respond to intermittent treatment with sulfadiazine and penicillin at home. Having
further failed to respond to 1,050,000 units of penicillin, terramycin therapy was
instituted on the 11th day of illness and continued for 53 days. Progressive gradual
improvement ensued. The temperature became normal on the 12th day of treatment, no
further embolic phenomena occurred, and the hemiplegia gradually disappeared except
for residual weakness of the left foot. Although the staphylococcemia promptly abated
under terramycin therapy, it should be noted that blood cultures were occasionally
positive for Staphylococcus aureus during the first four weeks of treatment and became
permanently negative only after the dose of terramycin had been increased to 6.0 gnL
per day for a week. Whether the increase in dosage or the evenitual healing of the
CHART 2. Case W.P. Subacute bacterial endocarditis due to Streptococcus fecalis.
mitral endocarditis was responsible for this is uncertain. At the time of discharge on
the 59th hospital day, recovery was apparently complete except for a persistent apical
systolic murmur and weakness of the left foot.
Case W.P., age 70, male. Chart 2. Subacute bacterial endocarditis due to Strepto-
coccus fecalis, the growth of which was inhibited by 2.0 jug./cc. of terramycin but not
by 10 usg./cc. of chloromycetin, 100 jg./cc. of streptomycin nor 5 un./cc. of penicillin.
This patient, admitted on February 2, 1950, approximately one month after the onset
of his illness, was started on terramycin therapy on March 15, after the diagnosis had
been established by the appearance of an apical systolic murmur, a palpable spleen,
scattered sparse petechiae, and repeatedly positive blood cultures. As shown in Chart
2, the original dosage of 4.0 gm. per day was probably inadequate. On the 11th day of
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treatment the dose was increased to 6.0 gin. per day, being maintained at this level for
19 days. As a result, the temperature returned to normal and repeated blood cultures
remained sterile. On the 30th day of treatment, because of anorexia, nausea, and
occasional vomiting, the dose was reduced to 4.0 gm. per day and was maintained at
that level until the 47th day, when treatment was discontinued. Beginning six days
later, however, blood cultures again became positive for Streptococcus fecalis, and it
was apparent that the infection had not been cured.
Case E.F., age 62, male. Chart 3. Subacute bacterial endocarditis due to Strepto-
coccus *iridans, the growth of which was inhibited by 1.0 ,ug./cc. of terramycin, by
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CHART 3. Case E.F. Subacute bacterial endocarditis due to Streptococcus viridanss.
0.03 un./cc. of penicillin, but not by 5.0 jAg./cc. of chloromycetin. This patient with
chronic rheumatic heart disease and mitral stenosis was admitted oni March 8, 1950,
approximately 2'/2 months after the probable onset of his disease and following an
embolic splenic infarction. Because of his serious condition he was immediately treated
with penicillin and aureomycin before the diagnosis was established or the result of
the initial blood cultures was known. Following the initial prompt clinical response
to treatment he was permitted to go without further medication until the suspected
diagnosis of subacute bacterial endocarditis could be fully confirmed by the reappear-
ance of bacteremia and fever. As shown in Chart 3, this occurred at the end of the
second hospital week. Terramycin therapy was then instituted and continued for 37
days. Blood cultures became sterile, and there was progressive clinical improvement.
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The occasional moderate elevations of temperature during the course of treatment are
quite similar to those observed during the successful treatment of subacute bacterial
endocarditis with penicillin2 and were'not considered to be necessarily indicative of
inadequate dosage or an unsatisfactory therapeutic response. On the 13th day of treat-
ment he developed blurring of vision in the right eye, which appeared to be due to
embolism of a retinal arteriole, and in the fifth week mild symptoms suggesting a
splenic infarction occurred. Comparable events may occur during penicillin treatment
without serious consequence or evidence that the emboli are infected.2 Eight days after
terramycin was discontinued, however, blood cultures became positive again for
Streptococcus ziridans, and clinical relapse occurred.
Case C.P., age 36, male. Chart 4. Pneumococcal lobar pneumonia, right lower lobe.
Admitted on the 2nd day of disease, acutely ill, blood culture negative. Pneumococcus
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CHART 4. Cases C.P., A.B., G.P., and A.T. Pneumococcal lobar pneumonia.
from sputum sensitive to 1.0 ,ug./cc. of terramycin. Following an initial loading dose
of terramycin of 1.0 gm. q.h.3x, he was treated through the 7th day with 3.0 gm. per
day. The temperature fell critically to normal within 36 hours; convalescence was
uneventful.
Case A.B., age 37, male. Chart 4. Pneumococcal lobar pneumonia, right middle lobe.
Admitted on the 1st day of disease, moderately ill, blood culture negative. Pneumo-
coccus from sputum sensitive to 0.5 ,ug./cc. of terramycin. Following an initial dose of
1.0 gm. of terramycin, he was treated with 3.0 gm. per day for 4 days and then with
1.5 gm. per day for 2 days. The temperature fell critically to normal within 24 hours,
the signs of pneumonia resolved rapidly; convalescence was uneventful.
Case G.P., age 60, male. Chart 4. Pneumococcal lobar pneumonia, right upper, right
middle, and left lower lobes. Admitted on the 3rd day of disease, acutely ill, auricular
flutter, blood culture negative. Pneumococcus from sputum sensitive to 0.5 ,ug./cc. of
terramycin. Following an initial loading dose of terramycin, 1.0 gm. q.h.3x, he was
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treated with 3.0 gm. per day until the 9th day. The temperature fell from 1050 F. to
normal within 18 hours; recovery was prompt and uneventful.
Case A.T., age 68, female. Chart 4. Pneumococcal lobar pneumonia, right middle,
right lower, and left lower lobes. Admitted on the 6th day of disease, acutely ill, blood
culture negative. Pneumococcus from sputum sensitive to 0.5 jLg./cc. of terramycin.
Treatment with terramycin consisted of a loading dose of 1.0 gm. q.h.3x, followed by
4.0 gm. per day for 32 days and then 3.0 gm. per day for 4V/2 days. There was
prompt clinical improvement with sharp reduction in temperature but low grade fever
WEEKS 3 4 5
CASV E.S.
103
101
IL~
LA# 100
ag99 B.GcoI,'ooJ4 0 V
itEa.c.IL
AM
4.0
AC 3.0
'a 1.0
CHART 5. Case E.S. Urinary tract infection, Streptococcus viridans bacteremia.
for several days, a phenomenon often encountered in old people treated late in the
disease with penicillin. Further convalescence was uneventful.
Case E.S., age 38, female. Chart 5. Subacute urinary tract infection with E. coli and
B. proteus vulgaris, acute Streptococcus viridans bacteremia. This patient with trans-
verse myelitis, paraplegia, and a nonfunctioning urinary bladder had had an afebrile
subacute urinary tract infection for approximately one month, which had failed to
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respond to treatment with sulfadiazine and streptomycin. While under treatment she
had a shaking chill and sharp rise in temperature to 1030 F. Blood culture showed
4 colonies per cc. of Streptococcus viridans. The sensitivity to terramycin of the
S. viridans was 1.0 ,ug./cc., of the B. proteus vulgaris from her urine > 2.0 < 4.0
/Ag./cc. Terramycin treatment was promptly instituted with an initial dose of 1.0 gm.
followed by 0.5 gm. q.2 h.12x and subsequent treatment for 3¼2 weeks as shown in
Chart 5. The blood culture was sterile in 24 hours, and both E. coli and B. proteus
vulgaris had disappeared from the urine cultures in 48 hours. The temperature was
normal within 96 hours and remained so except for a transient unexplained bout of
fever during the third week. As might have been expected, E. coli reappeared in the
urine one week after treatment was discontinued.
Case C.S., age 72, male. Urinary tract infection with E. coli and B. proteus. E. coli
sensitive to 4.0 ,ug./cc. of terramycin, B. proteus not tested. This patient with diabetes
mellitus and arteriosclerotic heart disease in congestive failure had developed a perineal
fistula and severe urinary tract infection following a prostatectomy. The infection had
not yielded to treatment with sulfadiazine, penicillin, streptomycin, or chloromycetin.
The effect of terramycin on the urinary tract infection was as follows:
Terramycin Urine cultures
Day gms./day E. coli B. proteus
1 ... ++ ++
2
3 2.5
4 3.0 +_
5-7 3.0
8-12 1.5 - -
13
Case E.D., age 72, female. Urinary tract infection with B. inucosus capsulatus. This
patient with generalized arteriosclerosis, diabetes mellitus, and renal calculus had
suffered approximately six months with a chronic cystitis which had failed to respond to
sulfadiazine, penicillin, and streptomycin. Two weeks before admission she had
developed an acute exacerbation. Cultures of the urine showed it to be heavily infected
with B. mucosus capsulatus, which was found to be sensitive to 5.0 Ag./cc. of terra-
mycin, to < 25.0 > 5.0 gg./cc. of streptomycin. After an initial dose of 1.0 gm. of
terramycin, she was treated with 0.4 gm. q.4 h. for 4 days followed by 0.25 gm. q.4 h.
for 2 days. The symptoms of cystitis rapidly subsided. Urine cultures were sterile on
the 3rd day and remained so until discharge on the 11th day.
Case J.G., age 46, male. Urinary tract infection with B. inucosus capsulatuts. This
patient, severely ill with hypertensive cardiovascular disease, diabetes mellitus, and
nephritis with azotemia, had had symptoms of cystitis for approximately one month.
On admission, cultures of the urine showed a heavy growth of B. nmucosus capsulatus,
which was found to be sensitive to 4.0 Ag./cc. of terramycin. After 4 days of penicillin
therapy without effect, he was treated with terramycin-initial dose 1.0 gm., then
0.5 gm. q.4 h. for 10 days. During the period of treatment there was considerable
reduction in the albuminuria, pyuria, hematuria, and bacilluria, but the infection was
not eliminated. Nausea and vomiting became quite troublesome, and the N.P.N. rose
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from 85 mg.%o to 117 mg.%o. It seemed possible under these conditions that the
excretion of terramycin in the urine might be inadequate to exert a bacteriostatic
effect. Consequently, on the 9th day of treatment, the concentration of terramycin was
determined in 4 samples of urine collected at 4:00, 5:00, 7:00, and 8:00 p.m., 0.5 gm.
of terramycin having been given at 4:00 p.m. In all 4 samples the concentration was
found to be 32 ,g./cc., a considerably smaller amount than would be expected with
normally functioning kidneys,' but still 8 times the concentration required to inhibit
the growth of the patient's strain of B. mucosus capsulatus. Subsequent treatment with
streptomycin also failed to eliminate the urinary tract infection in this patient.
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CHART 6. Case G.G. Cholangeitis lenta due to Streptococcus viridans.
Case A.P., age 56, female. Staphylococcal pyoderma. This patient with a diffuse,
exfoliative dermatitis covering her face, trunk, and extremities, developed a severe
bullous pyoderma of her fingers, palms, feet, and left lower leg and was admitted at
once. By the 4th day she was critically ill with spreading pyoderma and a temperature
of 102.80 F. Cultures of pus withdrawn from an unruptured bulla showed a heavy
growth of Staphylococcus aureus and a moderate growth of Staphylococcus albus.
Blood culture was negative. The Staph. aureus was sensitive to 1.0 jg./cc. of terra-
mycin, the Staph. albus to 0.5 sg./cc. Treatment with terranycin was initiated on
r3 I ar, a.oj
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the 4th day with 1.0 gm. q.h. 3x, followed by 0.5 gm. q.3 h. for 7 days and 0.25 gm.
q.4 h. for 1 day. The temperature fell rapidly and reached normal within a week;
the pyoderma subsided progressively and had disappeared by the 3rd day of treatment.
Case J.A., age 27, male. Buccal and penile fusospirochetosis. This patient, admitted
on the 7th day of illness, presented the picture of a severe ulcerative Vincent's infection
of the whole buccal mucosa and the glans penis, superimposed upon a preceding
vesiculopapular eruption which involved the skin of the face, arms, and trunk, and the
buccal mucous membranes. Smears from the gums and glans penis showed innumerable
fusiform bacilli and Vincent's spirochetes. After 3 days without improvement he was
treated with terramycin as follows: initial dose 1.0 gm. q.h. 3x, 0.5 gm. q.3 h. for
4 days, 0.25 gm. q.4 h. for 1 day. Within 24 hours fusiform bacilli and spirochetes
were no longer demonstrable in smears from the gums and only a few spirochetes were
seen in the smear from the glans penis. The lesions of the buccal mucosa and glans
penis subsided rapidly and were healed by the 6th day of treatment.
Case R.S., age 53, male. Influenza. Admitted on the 4th day of disease, acutely ill,
temperature 103.40 F. Terramycin, initial dose 1.0 gm. q.h. 3x, followed by 4.0 gm. per
day for 2¼2 days had no apparent effect on the course of the disease.
Case G.G., age 36, male. Chart 6. Cholangeitis lenta. This patient was admitted on
April 1, 1950, with a history of chills, fever, and general malaise for 8 days, which
developed suddenly 9 days after a transient attack of mid-abdominal pain. Physical
examination revealed only a slight icterus. As shown in Chart 6, he continued to run
a high fever, and on 2 occasions blood cultures were positive for Streptococcus
siridans. The diagnosis of cholangeitis lenta was finally established by a liver puncture
biopsy which showed diffuse cholangeitis and pericholangeitis. Cultures of the liver
tissue were positive for Streptococcus viridans similar to that obtained in blood
cultures and also showed a non-hemolytic gamma streptococcus. The Streptococcus
viridans was sensitive to 2.0 /Lg./cc. of terramycin. Terramycin therapy was instituted
on the 22nd day with an initial dose of 1.0 gm. q.h. 3x, followed by 6.0 gm. per day
for 8¼2 days. It was then reduced to 3.0 gm. per day for 4¼2 days. Within 96 hours
the patient had shown marked improvement and the jaundice was diminishing rapidly.
He appeared fully recovered by the 7th day of treatment, and further convalescence
was uneventful.
Discussion
The number of cases described in this preliminary report is too limited
and the variety of clinical material too great to warrant more than tentative
suggestions concerning some of the infections in which terramycin should
prove to be an effective antibiotic agent. Among these are pneumococcal
lobar pneumonia; staphylococcal infections, both focal and generalized;
alpha hemolytic streptococcal infections, including both S. viridans and
S. fecalis; urinary tract infections with gram-negative bacilli, including
some strains at least of E. coli, B. mucosus capsulatus, and B. proteus; and
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Vincent's fusospirochetosis. The apparent cure of Case E.S. with staphylo-
coccal endocarditis, of Case G.G. with severe diffuse intrahepatic cholange-
itis, and the prompt recovery of three cases of lobar pneumonia treated
early in the disease lend strong support to these suggestions.
In the two cases of subacute bacterial endocarditis the response to
terramycin appeared to be essentially the same as might have been expected
with adequate doses of penicillin for an equivalent length of time. Shortly
after terramycin was stopped, however, relapse occurred in both cases.
Whether more prolonged treatment would have been successful is uncertain
at present.
The four cases of urinary tract infection were selected to determine
whether infections which had not yielded to other chemotherapeutic and
antibiotic agents would respond to terramycin. While this occurred
promptly in three of the four cases, it is of course likely that reinfection of
the urinary tract in these cases will recur, and in fact it had done so in one
case (E.S.) within a week after treatment had been discontinued.
The dosage employed was somewhat arbitrary and may have been more
than necessary in some cases, particularly with respect to the initial or
loading dose. There is a suggestion, at least, that a single dose of 1.0 gm.
instead of three doses at hourly intervals would often be sufficient. Much
further study will be required to define the most appropriate dosage for
various infections. Equally uncertain at present is the minimum duration
of treatment that will be effective in preventing relapse.
The only untoward side effects observed were nausea, vomiting, and
frequent loose stools. As will be seen from Table 1, 7 cases had no nausea
or vomiting, 10 cases no vomiting, and 6 cases no frequency of stools. In
only 2 cases (W.P. when receiving 6.0 gm. daily and J.G. with nephritis
and azotemia) were nausea and vomiting troublesome. In 7 of the 8 cases
with loose frequent stools, this phenomenon occurred for 2 to 3 days with
2 to 4 stools per day. In only 1 case (C.S. with perineal fistula) was it
troublesome or persistent.
Summary
The results of terramycin therapy in 15 patients with various infections
have been described. The response to therapy in 12 was sufficiently prompt
and clear cut to warrant the suggestion that terramycin will prove to be a
valuable antibiotic agent for the treatment of a considerable variety of
human infections caused by terramycin-sensitive microorganisms.
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